Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Invitation to International Cardiothoracic congress
2011-06-01

Our Faculty of Health Sciences is pleased to announce the European Association for Cardiothoracic Surgeons Academy (EACTS) and Hannes Meyer Cardiothoracic Surgery Registrar Symposium, which will be taking place on our Bloemfontein Campus from 3 to 5 June 2011.

The congress first started in 2004 as the Hannes Meyer Registrar Congress, which was jointly hosted by the UFS and the Society of Cardiothoracic Surgeons of South Africa. This event was hosted on our Bloemfontein Campus annually, except in 2009, when the University of Cape Town was the host.

The focus of this year’s symposium is new techniques in perfusion and surgery, with specific emphasis on research methodology, inflammatory lung disease and cardiac surgery in children and adults, which can be performed without the aid of a heart-lung machine in developing countries.

Prof. Francis Smit, Head of the Department of Cardiothoracic Surgery in the Faculty of Health Sciences, says EACTS identified the UFS as the Sub-Saharan training unit they will support in terms of training. The first of these symposiums was accordingly hosted in 2010.

This year’s symposium will be attended by approximately 70 delegates from cardiothoracic units from across South Africa and 10 doctors from 6 African countries, as well as 30 perfusion technologists.

“We are fulfilling a leadership role in Africa and South Africa with this course,” says Prof. Smit.

Several international visitors will be present, like Prof. Paul Sergeant and Prof. Marko Turina, two previous EACTS presidents and Prof. Charles Yankah, a Ghanaian Cardiothoracic Surgeon from the Charite Medical University in Berlin. The current president of the European Board of Cardiovascular Perfusion (EBCP), Mr Frank Merkle, will also be one of three international speakers delivering lectures on perfusion technology.

You are invited to attend the conference on the following dates:

 
Date: 3 - 5 June 2011

Time: 09:00

Venue: Faculty of Health Sciences in the Francois Retief Building on our Bloemfontein Campus

 


 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept